Sign In
Buy ACET
$7.83
-0.280 (-3.45%)
At Close: Jun 03, 2026
Adicet (ACET) Up as Kidney Cancer Drug Gets FDA's Fast Track Tag
10:56am, Tuesday, 09'th Jul 2024
Adicet (ACET) gains as the FDA grants the Fast Track designation to ADI-270 for the potential treatment of a form of kidney cancer. A phase I study for this indication is set to begin in 2024.
3 Clinical-Stage Biotech Stocks to Buy for Multibagger Returns
05:05pm, Tuesday, 02'nd Jul 2024
One of the ways to make millions from the market is to identify and invest in early-stage companies. If the business takes off, multi-fold returns are in the offering.
Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma
07:00am, Monday, 24'th Jun 2024
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024
07:22pm, Monday, 10'th Jun 2024
Biotech stocks are always interesting from a trading perspective. With dozens of companies in the clinical-stage, positive news from trials can be a big catalyst for a scintillating rally.
Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis
07:00am, Wednesday, 05'th Jun 2024
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
05:41pm, Friday, 31'st May 2024
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference
07:00am, Wednesday, 29'th May 2024
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates
04:01pm, Tuesday, 14'th May 2024
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
07:00am, Tuesday, 07'th May 2024
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
05:10pm, Tuesday, 30'th Apr 2024
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
07:00am, Monday, 08'th Apr 2024
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
Why Adicet Bio (ACET) Stock Might be a Great Pick
09:41am, Thursday, 04'th Apr 2024
Adicet Bio (ACET) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Is Adicet Bio (ACET) Outperforming Other Medical Stocks This Year?
10:46am, Monday, 01'st Apr 2024
Here is how Adicet Bio, Inc. (ACET) and Adma Biologics (ADMA) have performed compared to their sector so far this year.
